-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Propanc Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2024.
- Propanc Biopharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$291K, a 30.3% increase year-over-year.
- Propanc Biopharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$1.41M, a 13% increase year-over-year.
- Propanc Biopharma, Inc. annual Operating Income (Loss) for 2024 was -$1.54M, a 13.5% increase from 2023.
- Propanc Biopharma, Inc. annual Operating Income (Loss) for 2023 was -$1.78M, a 10.8% increase from 2022.
- Propanc Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$1.99M, a 9.86% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)